Arkansas Egg Producer Recalls Free-Range Brown Eggs Due to Salmonella Risk

Black Sheep Egg Company of Arkansas is recalling free-range brown eggs due to salmonella contamination detected during FDA inspections. Consumers are advised to discard affected eggs with specific best-by dates and UPC codes to prevent illness.
An egg producer based in Walnut Ridge, Arkansas, has issued a recall of certain batches of free-range large brown eggs following contamination concerns flagged by federal health authorities. The Black Sheep Egg Company identified that eggs with best-by dates ranging from August 22 through October 31, 2025, are affected. The recall includes 12-count and 18-count cartons, which were distributed within Arkansas and Missouri from July 9 to September 17.
The U.S. Food and Drug Administration (FDA) conducted inspections at the processing facility and discovered 40 samples containing salmonella bacteria, with seven different strains identified. While none of these strains has been linked to an ongoing outbreak, the presence of salmonella poses a significant health threat.
Consumers are advised not to consume, serve, or sell the affected eggs. The recalled eggs can be discarded or returned to the point of purchase. Two UPC codes are associated with the affected products: 860010568507 and 860010568538.
Salmonella infection symptoms typically develop within 12 to 72 hours after ingestion and include diarrhea, fever, and abdominal cramps, usually lasting about a week. Vulnerable populations such as children, the elderly, and those with weakened immune systems are at increased risk of severe illness.
The recall underscores the importance of proper food safety practices in egg production and processing. Consumers are encouraged to stay informed and check for specific best-by dates and UPC codes on egg packaging.
Source: https://medicalxpress.com/news/2025-09-black-sheep-egg-company-arkansas.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Pre-Surgical Combination Therapy Enhances Survival in Rare Thyroid Cancer Patients
Combining pembrolizumab with targeted therapies significantly improves survival and surgical resection rates in patients with aggressive BRAF-mutated anaplastic thyroid cancer.
New Biomarker Panel Enhances Prediction of CKD Progression in Children
A groundbreaking biomarker panel developed by Yale researchers improves the prediction of chronic kidney disease progression in children, supporting personalized care and better outcomes.
Underutilization of Healthcare Interpreters Highlights Need for Better Education and Awareness
Research highlights the underuse of professional healthcare interpreters in Australia, emphasizing the need for improved awareness, training, and reliance on qualified language services to enhance patient safety and health outcomes.
Prozac Enhances Brain Plasticity by Modulating Energy Systems in Key Neurons
New research shows that Prozac promotes brain plasticity by altering energy management in key neurons, potentially improving depression treatment outcomes.



